The primary theoretical safety concern is sustained activation of the HGF/c-Met proto-oncogenic pathway, which could theoretically promote tumor initiation or growth
Improves overall liver function and supports normal metabolic processes
Targeting the PD-1/PD-L1 immune evasion axis with DNA aptamers as a novel therapeutic strategy for the treatment of disseminated cancers
While combining peptides into one syringe can make administration more convenient (fewer injections), improper mixing can: - Reduce their therapeutic potency - Lead to unwanted chemical reactions - Waste the treatment potential of an otherwise powerful therapy The rules of thumb: Peptides that can be mixed: BPC157, TB4, GHK-Cu, CJC/Ipamorelin, Tesamorelin, Semorelin, TA1, Pinealon, Epithalon, Selank Peptides that should not be combined: Semaglutide, Tirzepatide, Retatrutide, Melanotan, VIP, Pentosan Combine separately: NAD+, MOTS-c, SS-31 Have more questions about peptides or precision longevity care